In this webinar, John McMurray and Giuseppe Mancia discuss the management of CV patients in the context of COVID-19, focussing on renin-angiotensin system blockers inhibitors and the latest evidence in COVID-19 and hypertension management.
Management of CV patients in the context of COVID-19: What have we learnt?
8 Jul 2020
Cardiology
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given